Fitish RX Review: Published Prices, but Important Enrollment Terms Remain Unclear

Fitish RX makes its headline offer relatively easy to understand: an online evaluation, prescription medication if approved, and delivery at a published price. The harder question is what a patient agrees to after choosing that offer. A monthly supply, a three-month bundle and a recurring shipment describe different things, and none alone explains when a card is charged or how future orders stop. For adults comparing commitments rather than just advertised rates, those distinctions are central to evaluating this service.

This review examines Fitish RX’s public documentation consulted October 19, 2026. The business describes itself as a cash-pay telehealth wellness clinic offering compounded semaglutide with B6, injectable tirzepatide, oral tirzepatide tablets and a separate microdosing program. Its pages provide useful prices and contact routes, but leave significant enrollment terms unresolved. The purpose here is to separate documented services from unanswered contractual questions—not to recommend a medication, verify professional licenses or assume that missing public terms necessarily mean unfavorable terms.

At a glance

Clinical organization: The privacy notice identifies Fitish, LLC together with DrTelx, the affiliated professional entity whose licensed providers deliver care through fitishrx.com.
Sources: [6]
Semaglutide price: Compounded semaglutide with B6 is advertised at $219 per monthly supply, including consultation, medication if approved and shipping, with no separate consultation or membership fee.
Sources: [7]
Tirzepatide choices: Compounded injectable tirzepatide and oral tirzepatide tablets are each advertised at $339 per monthly supply, including consultation, medication if approved and shipping.
Sources: [13] [10]
Microdosing period: The microdosing page advertises semaglutide at $179 and tirzepatide at $269 per 28-day supply, while also using monthly-supply language elsewhere on the page.
Sources: [14]
Cancellation boundary: The website terms allow termination of site services but do not specify how to stop future clinical charges or shipments; returns are referred to a separate policy unavailable in the consulted documentation.
Sources: [8]

Start with the agreement, not just the advertised plan

Fitish RX’s website terms identify FITISH as the site operator. Its health privacy notice names Fitish, LLC and DrTelx, describing the latter as the affiliated professional entity whose licensed providers deliver care through the website. That division matters when identifying who manages an account, who makes a prescribing decision and who holds clinical records. The documents establish named participants, but this review did not independently verify their credentials or the licenses of individual treating professionals.

The entry point is described as a virtual evaluation from home without an in-person visit. A licensed provider reviews the intake, and a prescription follows only if clinically appropriate. The semaglutide page specifically describes an online questionnaire about health and goals. This is a conditional clinical service, not an unconditional medication purchase. Before authorizing payment, a prospective patient should establish what happens financially if the review ends without a prescription.

The consulted documentation does not resolve that denial scenario or provide a complete treatment-specific enrollment agreement. A useful next step is to request the terms that apply to the selected product, rather than relying solely on general website provisions. Our guide to reviewing enrollment terms explains the distinction. For Fitish RX, the key missing connection is between completing intake, accepting a clinical plan and authorizing any continuing financial obligation.

Sources: [12] [6] [8] [4] [7]

What the published prices actually cover

Fitish RX publishes concrete prices rather than requiring every reader to complete intake first. Compounded semaglutide with B6 costs $219 for a monthly supply. Compounded tirzepatide, described on its product page as a subcutaneous injection, costs $339 for a monthly supply. Oral tirzepatide tablets are separately listed at $339 for a monthly supply. Each offering requires a medical evaluation and prescription; the oral and injectable presentations should not be treated as interchangeable simply because their advertised prices match.

The standard semaglutide and injectable tirzepatide pages explicitly include the provider consultation, medication if approved and shipping, with no separate consultation or membership fee. The oral tablet page also includes consultation, approved medication and shipping. These are meaningful inclusions, but they do not establish that laboratory work, administration supplies or outside services are covered. Those items are not clearly addressed in the consulted documentation, so a written quote should identify any additional patient responsibility.

The table summarizes the displayed offers without turning monthly bundle rates into assumed upfront charges. Fitish RX says bundle pricing is applied during intake. It also advertises savings of 10% for three-month bundles and 20% for six-month bundles; those are the provider’s stated percentages, not independently calculated savings. The different microdosing period deserves separate treatment because 28 days is not the same as a calendar month.

Fitish RX advertised medication prices; evaluation and prescription are required.
Offering	Published supply price	Bundle or period conditions
Compounded semaglutide + B6	$219 per monthly supply	Three months: $195/month; six months: $175/month. Payment timing unspecified.
Compounded tirzepatide, subcutaneous injection	$339 per monthly supply	Three months: $305/month; six months: $270/month. Payment timing unspecified.
Oral tirzepatide tablets	$339 per monthly supply	Three months: $305/month; six months: $270/month. Payment timing unspecified.
Microdosing semaglutide	$179 per 28-day supply	Page also uses monthly language; additional discounts excluded.
Microdosing tirzepatide	$269 per 28-day supply	Page also uses monthly language; additional discounts excluded.

Sources: [7] [13] [10] [14]

Bundles leave the size of the commitment unresolved

For semaglutide, the three-month bundle is advertised at $195 per month and the six-month bundle at $175 per month. For both injectable and oral tirzepatide, the corresponding advertised rates are $305 and $270 per month. Those figures describe pricing associated with a package duration. They do not, by themselves, establish whether payment is collected all at once, charged in installments or handled through another arrangement presented during intake.

The consulted pages do not establish the total amount due at enrollment, a minimum commitment or the consequences of leaving a bundle early. They also do not specify whether a package results in one shipment or multiple shipments containing particular quantities. Readers should therefore avoid interpreting a six-month label as either six months prepaid or six months freely cancelable. Both conclusions would go beyond what the public documentation establishes.

Fitish RX’s general terms also say prices may change without notice. The reviewed material does not explain whether an accepted bundle protects its rate or how a changed price would affect a later order. Our explanation of monthly prices and billing commitments provides a framework for these questions. Here, the practical request is straightforward: obtain the collection schedule, commitment length and treatment of unused portions in writing before selecting the discount.

Sources: [7] [13] [10] [8]

Stopping the website relationship is not a documented billing stop

The general terms say a user may terminate the Terms of Service by notifying the company that they no longer wish to use its services, or by ceasing to use the site. That language does not specify how an existing patient cancels a future medication order, withdraws payment authorization or stops a shipment already moving toward fulfillment. It would be unsafe to treat simply closing the browser or abandoning the portal as a documented cancellation procedure.

Similarly, the injectable tirzepatide page says medication ships on a monthly cadence. That establishes a described shipping rhythm, not proof of an automatically renewing subscription or its cancellation rules. The consulted pages do not identify renewal dates, cancellation deadlines, pause options or the point after which an order cannot be stopped. The distinctions in our guide to cancellation notice and order status are especially relevant to this unresolved part of the Fitish RX offer.

Refund terms are also incomplete. The website refers returns and exchanges to a Return Policy, but that policy was not available in the consulted documentation. No clear refund rule was established for clinical denial, unused supplies or ending a bundle early. Separately, replying STOP cancels the SMS service and triggers a final confirmation text. That is a communication opt-out, not a documented method for canceling treatment, payments or pharmacy shipments.

Sources: [13] [8] [5]

Eligibility and microdosing describe different service scopes

The standard weight-management offering is directed to adults whose BMI and medical history meet clinical eligibility criteria. Fitish RX says a licensed provider reviews every intake before prescribing, while its privacy policy says it does not knowingly provide services to people younger than 18. The consulted documentation does not supply numeric BMI thresholds, required laboratory testing or a complete screening protocol. Eligibility therefore cannot be determined from the published product price or a short marketing description.

Microdosing has its own stated scope: the dedicated page calls it general wellness and cosmetic support, explicitly not a weight-loss or weight-management program. Yet other GLP-1 pages suggest that some people below the standard program’s BMI threshold may be candidates, subject to provider review. That creates a presentation tension worth clarifying. A patient should ask which program is actually being offered and what clinical purpose the treating professional is proposing, rather than assuming it is a discounted version of standard weight management.

The microdosing page lists semaglutide at $179 and tirzepatide at $269 for a 28-day supply, while its introductory block says “From $179” for a monthly supply. It also excludes additional discounts because the program is already discounted. The discrepancy leaves the actual supply and billing interval needing confirmation. The page’s cosmetic and wellness framing documents how Fitish RX markets the program; it does not establish clinical benefits, lower risk or equivalence to studied treatment regimens.

Sources: [13] [11] [10] [14] [2] [3]

Pharmacy and delivery promises need operational detail

Fitish RX says compounded semaglutide is prepared by a state-licensed sterile compounding pharmacy. Its tirzepatide page describes discreet monthly shipping from a licensed compounding pharmacy, and the oral page also refers to a state-licensed compounding pharmacy. These are provider descriptions, not independent license checks. The consulted documentation does not name the dispensing pharmacies, preventing a reader from using these pages alone to identify which organization would prepare and dispense a particular prescription.

Shipping is included in the published standard product prices, but arrival timing is not established. The reviewed pages do not specify clinical review turnaround, preparation time, transit time, carrier, tracking arrangements or refrigeration procedures. A monthly shipping cadence is not an arrival guarantee. Fitish RX directs damaged, defective or incorrect order concerns to theclinic@fitish.com and says its team will address them, but that statement does not promise a particular replacement or refund remedy.

FDA’s general guidance adds an important delivery boundary: do not use an injectable GLP-1 product that arrives warm or with insufficient refrigeration, and contact the provider or dispensing pharmacy. This is not evidence of a Fitish RX shipping problem. It explains why pharmacy identity and an actionable delivery-issue process matter before ordering. Patients should know whom to contact and how the company handles a questionable shipment without assuming the included shipping charge covers every possible resolution.

Sources: [10] [13] [7] [9] [1]

Follow-up is advertised; response obligations are not

Fitish RX advertises regular check-ins, progress tracking and direct messaging with the care team. The injectable tirzepatide page is more specific, describing ongoing portal support for questions and clinician-directed adjustments at no added cost. Those statements establish that the advertised service extends beyond an initial prescription. They do not specify a check-in calendar, guaranteed response time, staffing schedule or around-the-clock availability, so patients should clarify the operational meaning of ongoing support.

The contact page separates treatment and product issues at theclinic@fitish.com, orders and existing-patient questions at orders@fitish.com, and general inquiries at info@fitish.com. It also publishes 1-800-576-8990 and a mailing address for Fitish, LLC at 2311 East Loop 820 North, Fort Worth, Texas 76118. Multiple contact routes are useful, but none is explicitly established in the consulted material as the required channel for canceling recurring charges or obtaining a binding refund decision.

For continuity, the privacy notice recognizes access to a copy of protected health information, including an electronic copy where readily producible, subject to limited exceptions and a possible reasonable cost-based fee. That is distinct from a promise of free records transfer or immediate access. Our guide to platform, clinician and pharmacy responsibilities helps organize these boundaries. With Fitish RX, ask which entity handles records, clinical follow-up, billing disputes and pharmacy complaints.

Sources: [4] [13] [9] [6]

Confirm availability and product identity before authorizing payment

Fitish RX says it does not accept insurance and operates as a cash-pay telehealth service. That establishes how the service presents payment, not whether any particular insurance plan would reimburse an expense. Geography is another unresolved enrollment gate: the general terms reserve the right to limit sales by person, region or jurisdiction, but the consulted documentation provides no confirmed state-by-state service list. A Texas mailing address does not establish nationwide prescribing or shipping availability.

Product identity also deserves explicit confirmation. Fitish RX acknowledges that its compounded preparations are not FDA approved. The oral tirzepatide page states that no FDA-approved oral tirzepatide product exists and distinguishes approved injectable products. FDA approval belongs to specific products, not the clinic or its pharmacy. The consulted documentation does not establish an actual dispensing offer for the approved commercial alternatives mentioned on the site, so readers should not assume those are available through the same enrollment process.

FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Compounded preparations do not undergo FDA premarket review for safety, effectiveness and quality; nonapproval alone does not prove clinical inequivalence. These distinctions do not settle whether a Fitish RX plan is appropriate for an individual. They do make the exact formulation, route, dispensing pharmacy and clinical rationale important parts of an informed discussion before accepting the financial terms.

Sources: [4] [8] [10] [7] [1]

Questions & answers

Does Fitish RX require payment for an entire three- or six-month bundle upfront?

The consulted pages do not establish that. They advertise monthly bundle rates and say the pricing is applied during intake, but do not specify collection timing, the total due at enrollment or a minimum commitment. Ask for the exact payment schedule and early-exit terms before accepting a bundle; the package label alone does not answer those questions.

Sources: [7] [13] [10]

Can I cancel Fitish RX by replying STOP to a text?

STOP is documented as canceling the SMS service, followed by one confirmation message. It is not documented as canceling medication orders, portal care or billing. The general website termination clause does not fill that gap. Request the treatment-specific cancellation channel, effective date and handling of any pending pharmacy order, and retain the written confirmation.

Sources: [5] [8]

What happens to my payment if the clinician does not approve medication?

The standard product pages condition medication on approval, but the consulted documentation does not state a denial-refund rule. Including consultation in the advertised price does not establish whether a declined applicant receives all, part or none of a payment back. Clarify when the charge occurs and which services, if any, remain payable after a clinical denial.

Sources: [7] [13] [10]

Is Fitish RX microdosing billed monthly or every 28 days?

The public page uses both descriptions. Its detailed price block specifies a 28-day supply at $179 for semaglutide or $269 for tirzepatide, while the introductory offer says monthly supply. Neither wording establishes the actual billing schedule. Ask separately about supply duration, shipment frequency and charge dates, and remember that this program excludes additional discounts.

Sources: [14]

Who should handle a damaged or incorrect Fitish RX order?

Fitish RX directs damaged, defective and incorrect order concerns to theclinic@fitish.com. Its statement that the team will address the problem does not specify a refund or replacement entitlement. For an injectable GLP-1 delivery that arrives warm or inadequately refrigerated, FDA advises not using it and contacting the provider or dispensing pharmacy to resolve the concern.

Sources: [9] [1]

Does the $339 oral tirzepatide offer mean an FDA-approved tablet?

No. Fitish RX explicitly describes compounded oral tirzepatide as not FDA approved and says there is no FDA-approved oral tirzepatide product. The $339 monthly-supply offer includes consultation, medication if approved and shipping, but that price does not establish clinical equivalence to an approved injection. Confirm the actual product and discuss its rationale with the treating clinician.

Sources: [10] [1]

Our assessment

Fitish RX documents more than a vague starting price: it identifies several formulations, publishes standard and bundle rates, includes consultation and shipping, and describes portal follow-up with named contact routes. Those are useful strengths for comparison. Its public documentation is less complete at the point where a patient needs to understand the commitment: payment collection, renewal authorization, cancellation timing, clinical-denial refunds and unused bundle value remain unresolved. A reasonable next step is to obtain product-specific written terms and pharmacy details before authorizing payment. Clear answers could materially improve the offer’s transparency; their absence from the consulted pages is a reason to ask, not proof of misconduct or a prediction of treatment quality.

Visit Fitish RX’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Fitish RX Review: Published Prices, but Important Enrollment Terms Remain Unclear

At a glance

01Start with the agreement, not just the advertised plan

02What the published prices actually cover

03Bundles leave the size of the commitment unresolved

04Stopping the website relationship is not a documented billing stop

05Eligibility and microdosing describe different service scopes

06Pharmacy and delivery promises need operational detail

07Follow-up is advertised; response obligations are not

08Confirm availability and product identity before authorizing payment